Delivery Order SPE2DB20D3101-SPE2DB24FRJB7
- Not listed
- This is a $2,810.78 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Sprycel 20 mg tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $13,025.40 contract is for the supply of the prescription drug Sprycel 100 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $5,665.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order as a...
- The Defense Logistics Agency (DLA) awarded a $11,606.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packages) on January 20, 2026, with an ultimate completion date of January 21, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $19,021.43, is for the delivery of the pharmaceutical product Sprycel 140 mg tablet, a brand name cancer medication. The contract has an ultimate completion date of April 1, 2024. This award is a task order issued under an indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $30,539.06 to supply Sprycel 50 mg tablets (60-count units) with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as AmerisourceBergen's corporate office in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sprycel 100 mg tablets to support federal healthcare programs. The $5,322.66 firm fixed-price contract has an ultimate completion date of July 18, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,285.55 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg Tablet 30s. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,304.15 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency issued a $5,803.13 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for Sprycel 100 mg tablets (30 count). The order is issued under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRJB7Delivery Order
This is a $15,065.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Sprycel 140 mg tablets, a specialty medication, with a completion date of May 2, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 5/1/24 |